Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The nocebo effect challenges the non-medical infliximab switch in practice.
Boone NW, Liu L, Romberg-Camps MJ, Duijsens L, Houwen C, van der Kuy PHM, Janknegt R, Peeters R, Landewé RBM, Winkens B, van Bodegraven AA. Boone NW, et al. Among authors: winkens b. Eur J Clin Pharmacol. 2018 May;74(5):655-661. doi: 10.1007/s00228-018-2418-4. Epub 2018 Jan 24. Eur J Clin Pharmacol. 2018. PMID: 29368188 Free PMC article.
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
Bevers N, Van de Vijver E, Aliu A, Rezazadeh Ardabili A, Rosias P, Stapelbroek J, Bertrams Maartens IA, van de Feen C, Escher H, Oudshoorn A, Teklenburg S, Vande Velde S, Winkens B, Raijmakers M, Vreugdenhil A, Pierik MJ, van Rheenen PF. Bevers N, et al. Among authors: winkens b. J Pediatr. 2023 May;256:113-119.e4. doi: 10.1016/j.jpeds.2022.12.016. Epub 2022 Dec 21. J Pediatr. 2023. PMID: 36563900 Free article. Clinical Trial.
Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease.
Rezazadeh Ardabili A, van Esser D, Wintjens D, Cilissen M, Deben D, Mujagic Z, Russ F, Stassen L, Van Bodegraven AA, Wong D, Winkens B, Jonkers D, Romberg-Camps M, Pierik MJ. Rezazadeh Ardabili A, et al. Among authors: winkens b. J Crohns Colitis. 2023 Jul 5;17(7):1079-1088. doi: 10.1093/ecco-jcc/jjad023. J Crohns Colitis. 2023. PMID: 36795060 Free PMC article.
Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors.
Janssen LM, Rezazadeh Ardabili A, Romberg-Camps MJL, Winkens B, van den Broek RJ, Hulst J, Verwijs HJA, Keszthelyi D, Jonkers DMAE, van Bodegraven AA, Pierik MJ, Mujagic Z. Janssen LM, et al. Among authors: winkens b. Aliment Pharmacol Ther. 2023 Nov;58(10):1041-1051. doi: 10.1111/apt.17718. Epub 2023 Sep 19. Aliment Pharmacol Ther. 2023. PMID: 37724651
Risk of impaired nutritional status and flare occurrence in IBD outpatients.
Spooren CEGM, Wintjens DSJ, de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Masclee AAM, Winkens B, Jonkers DMAE, Pierik MJ. Spooren CEGM, et al. Among authors: winkens b. Dig Liver Dis. 2019 Sep;51(9):1265-1269. doi: 10.1016/j.dld.2019.05.024. Epub 2019 Jun 15. Dig Liver Dis. 2019. PMID: 31213405
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
Rombout-Sestrienkova E, Winkens B, van Kraaij M, van Deursen CTBM, Janssen MCH, Rennings AMJ, Evers D, Kerkhoffs JL, Masclee A, Koek GH. Rombout-Sestrienkova E, et al. Among authors: winkens b. J Clin Apher. 2021 Jun;36(3):340-347. doi: 10.1002/jca.21867. Epub 2020 Dec 24. J Clin Apher. 2021. PMID: 33368569 Free PMC article.
321 results